Pomalid 2mg Capsules (Pomalidomide 2mg)

Description

Pomalid 2 mg Capsule is used along with dexamethasone to treat a type of blood cancer known as multiple myeloma in patients who have already received at least 2 therapies including lenalidomide and a proteasome inhibitor, and has not improved during or within 60 days of completion of the last therapy. This medicine is not recommended for use in patients below 18 years of age.

Side effects

Major & minor side effects for Pomalid 2 mg Capsule
Blood in urine and stools
Chest tightness
Chills
Cough
Dry mouth
Dizziness and Drowsiness
Difficulty in breathing
Headache
Loss of appetite
Lower back or side pain
Nausea and vomiting
Unusual weight gain or loss
Stomach pain
Fainting

Uses of Pomalid 2 mg Capsule

What is it prescribed for?
Multiple Myeloma
This medicine is used in combination with dexamethasone for the treatment of multiple myeloma, a type of blood cancer in patients who have already received at least 2 therapies including lenalidomide and a proteasome inhibitor, and has not improved during or within 60 days of completion of the last therapy.

Related Product

When not to use?

Allergy
This medicine is not recommended for use in patients with a known allergy to Pomalidomide or any other inactive ingredients present along with this medicine.
Pregnancy
This medicine is not recommended for use in pregnant women due to the increased risk of harmful effects on the unborn baby.

Warnings

Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women due to the increased risk of serious adverse effects on the unborn baby.
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding for a specific period of time or prescribe an alternative medicine based on your clinical condition.
General warnings
Use in Children
This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.
Driving or operating machinery
This medicine may cause symptoms such as drowsiness, dizziness, tiredness, muscle weakness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.
Hematologic Toxicities
This medicine should be used with caution in patients suffering from hematological toxicities due to the increased risk of worsening of the patient’s condition. It is recommended to monitor complete blood picture weekly for the first eight weeks and monthly thereafter while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Neuropathy
This medicine should be used with extreme caution in patients with or at risk for neuropathy due to the increased risk of worsening of the patient’s condition. Report any unusual symptoms to the doctor immediately. Close monitoring of the clinical condition, corrective measures, appropriate patient/caregiver counseling, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
Smoking
Smoking is not recommended during the treatment with this medicine, since it may alter the desired effects of Pomalid 2 mg Capsule. Report any unusual symptoms to the doctor on priority.
Thromboembolism
This medicine may cause venous and arterial thromboembolic events and should be used with extreme caution in patients with prior thrombosis or any known risk factors. Prophylactic antithrombotic measures are recommended and the choice of regimen should be based on the assessment of the patient’s underlying risk factors. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Tumor lysis syndrome (TLS)
This medicine may cause a condition called Tumor lysis syndrome (TLS) an abnormality that occurs as a complication of cancer therapy, where a large number of tumor cells are killed and released into the bloodstream. Report signs and symptoms of tumor lysis syndrome such as diarrhea, muscle cramps, weakness, numbness, nausea, vomiting, etc. to the doctor immediately. Close monitoring of the clinical condition, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Dosage

Missed Dose
Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

General Instructions
Take this medicine exactly as instructed by the doctor. Do not take in larger or smaller amounts than prescribed. Report any unusual symptoms to the doctor immediately. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.